• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    12/20/23 1:16:08 PM ET
    $ACON
    $AGRI
    $ANY
    $AON
    Medical Specialities
    Health Care
    Metal Fabrications
    Industrials
    Get the next $ACON alert in real time by email

    Steelcase Inc. (NYSE:SCS) shares moved higher during Wednesday's session following quarterly results.

    Steelcase posted upbeat earnings for its third quarter, while sales missed estimates. The company said it sees fourth-quarter adjusted earnings of 19 cents to 23 cents per share on revenue of $765 million to $790 million.

    Steelcase shares gained 12.7% to $14.31 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • ParaZero Technologies Ltd. (NASDAQ:PRZO) climbed 86.4% to $1.3050. ParaZero successfully completed its drone safety project with a Fortune 500 leading automotive manufacturer.
    • Polished.com Inc. (NYSE:POL) shares climbed 77.3% to $1.8794. Jerald Hammann, a Polished.com shareholder, urged shareholders concerned about their investment in Polished.com to collaborate to increase the effectiveness of their actions.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) gained 35% to $5.65.
    • Applied UV, Inc. (NASDAQ:AUVI) rose 29.5% to $2.38 after the company's recent announcement on successfully integrating its PURO and Airocide businesses into its Sterilumen subsidiary.
    • Aclarion, Inc. (NASDAQ:ACON) shares rose 24.7% to $0.3650 after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)."
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) gained 22.7% to $1.6197. RedHill and U.S. Army announced Opaganib and RHB-107 combinations with remdesivir show distinct synergistic effect against ebola.
    • Canaan Inc. (NASDAQ:CAN) gained 20.8% to $2.6950.
    • Sphere 3D Corp. (NASDAQ:ANY) rose 19.4% to $2.3300.
    • Asset Entities Inc. (NASDAQ:ASST) shares gained 18% to $0.4599. Asset Entities recently announced the launch of Ternary V2, the next generation of Ternary’s Stripe-verified digital community payment processing platform.
    • Applied UV, Inc.(NASDAQ:AUVI) gained 17.4% to $2.1502 after jumping around 21% on Tuesday. Applied UV recently announced successful integration of its PURO UV disinfection and airocide food preservation units to optimize cost reduction and expand global growth opportunities.
    • Beyond Air, Inc. (NASDAQ:XAIR) shares gained 17.3% to $1.9950. Beyond Air, Director Robert Carey, reported the purchase of 1.2 million shares at an average price of $1.635 per share in Form 4 filing on Tuesday.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) rose 15.1% to $5.54.
    • MacroGenics, Inc. (NASDAQ:MGNX) gained 12.7% to $10.41. Citigroup upgraded Macrogenics from Neutral to Buy and raised the price target from $7 to $13.
    • Clear Channel Outdoor Holdings, Inc. (NYSE:CCO) gained 12.5% to $1.89. Clear Channel Outdoor named David Sailer as Executive Vice President, CFO, effective as of March 1, 2024 and reaffirmed guidance for FY23.
    • Liquidia Corporation (NASDAQ:LQDA) gained 11.5% to $8.79.
    • Despegar.com, Corp. (NYSE:DESP) jumped 11% to $10.10. B. Riley Securities maintained Despegar.com with a Buy and raised the price target from $12 to $15.
    • HIVE Digital Technologies Ltd. (NASDAQ:HIVE) gained 9.9% to $4.2090. HIVE Digital recently announced a $25 million bought deal private placement of 5m special warrants at a price of $5/warrant financing.
    • DXC Technology Company (NYSE:DXC) fell 9.2% to $22.73. DXC Technology named Raul Fernandez as interim President and CEO, succeeding Mike Salvino, effective immediately. The company reaffirmed its third-quarter guidance and FY24 free cash flow guidance of $800 million.
    • The Toro Company (NYSE:TTC) surged 8.2% to $96.54 after the company reported better-than-expected fourth-quarter financial results and issued guidance.

     

    Losers

    • Jin Medical International Ltd. (NASDAQ:ZJYL) shares fell 46.4% to $61.00 after gaining around 12% on Tuesday. Last Thursday, before the market open, the company announced that it had signed a preliminary Memorandum of Understanding (MOU) with Jiangsu Zhongjin Kanglu Information Technology Co., Ltd.
    • Vast Renewables Limited (NASDAQ:VSTE) fell 44.4% to $6.66 after dipping 14% on Tuesday.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares dipped 44.2% to $1.3550 after the company announced pricing of a $125 million public offering of common stock.
    • Harbor Custom Development, Inc. (NASDAQ:HCDI) fell 31% to $0.2199. Harbor Custom Development recently announced Chapter 11 bankruptcy protection filing.
    • KULR Technology Group, Inc. (NASDAQ:KULR) shares fell 29.1% to $0.2099 after the company reported pricing of $900,000 public offering of common stock.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 28.4% to $0.0146.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) dipped 26.2% to $0.4274. Agriforce Growing Systems filed for offering of up to 8.72 million shares of common stock by the selling stockholders.
    • argenx SE (NASDAQ:ARGX) shares fell 24.3% to $342.54 after the company disclosed topline results from the ADDRESS study evaluating efgartigimod subcutaneous in adults with pemphigus vulgaris and pemphigus foliaceus.
    • Nogin, Inc. (NASDAQ:NOGN) fell 24% to $0.1230 after surging 42% on Tuesday.
    • Northann Corp. (NASDAQ:NCL) tumbled 22.2% to $1.40.
    • Meiwu Technology Company Limited (NYSE:WNW) dipped 21.6% to $2.1701.
    • Know Labs, Inc. (NYSE:KNW) fell 20% to $0.60 following fourth-quarter results.
    • Fluence Energy, Inc. (NASDAQ:FLNC) declined 17.9% to $22.34. Energy Storage News reported Fluence customer seeking refund for Diablo Bess Epc Contract, citing 'defects and chronic failures'.
    • CARGO Therapeutics, Inc. (NASDAQ:CRGX) fell 11.4% to $18.16.
    • Immunovant, Inc. (NASDAQ:IMVT) shares fell 11.4% to $36.79.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 10.7% to $1.4004 after jumping 55% on Tuesday. The company recently announced FDA approval of eflornithine, a drug they divested to US WorldMeds, for treating high-risk neuroblastoma patients who responded partially to prior therapies.
    • FedEx Corporation (NYSE:FDX) shares fell 10.5% to $250.60 after the company posted weaker-than-expected earnings for its second quarter and lowered its full-year revenue outlook..
    • Diversified Energy Company PLC (NYSE:DEC) declined 9.2% to $14.82.
    • MannKind Corporation (NASDAQ:MNKD) fell 7.2% to $3.63.
    • Aon plc (NYSE:AON) fell 6.8% to $291.56 after the company announced it will acquire NFP.

     

    Now Read This: Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AGRI
    $ANY
    $AON

    CompanyDatePrice TargetRatingAnalyst
    FedEx Corporation
    $FDX
    3/20/2026$360.00Reduce → Hold
    HSBC Securities
    Immunovant Inc.
    $IMVT
    3/20/2026$28.00Mkt Perform
    Bernstein
    Fluence Energy Inc.
    $FLNC
    3/20/2026Hold
    Needham
    FedEx Corporation
    $FDX
    3/20/2026$383.00 → $426.00Buy
    TD Cowen
    Fluence Energy Inc.
    $FLNC
    3/19/2026Sell → Neutral
    Guggenheim
    argenx SE
    $ARGX
    3/10/2026Hold → Buy
    Deutsche Bank
    Strive Inc.
    $ASST
    3/10/2026$12.00Buy
    B. Riley Securities
    MannKind Corporation
    $MNKD
    2/27/2026$3.50Outperform → Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $ACON
    $AGRI
    $ANY
    $AON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Janey Gregory S

    4 - TORO CO (0000737758) (Issuer)

    3/26/26 9:23:15 AM ET
    $TTC
    Tools/Hardware
    Consumer Discretionary

    SEC Form 4 filed by Prentiss Christopher B

    4 - MANNKIND CORP (0000899460) (Issuer)

    3/25/26 9:30:09 PM ET
    $MNKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Castagna Michael

    4 - MANNKIND CORP (0000899460) (Issuer)

    3/25/26 9:30:07 PM ET
    $MNKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AGRI
    $ANY
    $AON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Castagna Michael bought $259,000 worth of shares (100,000 units at $2.59), increasing direct ownership by 4% to 2,575,911 units (SEC Form 4)

    4 - MANNKIND CORP (0000899460) (Issuer)

    3/10/26 9:30:02 PM ET
    $MNKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Pham Benjamin bought $115,095 worth of shares (14,114 units at $8.15) (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/19/26 8:00:23 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Chief Legal Officer Beirne Brian Logan bought $100,387 worth of shares (11,500 units at $8.73), increasing direct ownership by 310% to 15,204 units (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/17/26 8:02:53 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ACON
    $AGRI
    $ANY
    $AON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025

    KFAR SABA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today issued a Letter to Shareholders from Ariel Aron, Chief Executive Officer. Dear Shareholders and Partners, 2025 will be remembered as a transformative year and a significant strategic turning point for ParaZero. I am writing to you today as we stand at the threshold of a new era. ParaZero has successfully completed a fundamental transformation, evolving from a pioneer in drone safety components into a leader in multi-layered au

    3/27/26 7:00:00 AM ET
    $PRZO
    Military/Government/Technical
    Industrials

    KULR Technology Group Sets Fourth Quarter and Full Year 2025 Earnings Call for Tuesday, March 31, 2026 at 4:30 p.m. ET

    HOUSTON, March 26, 2026 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE:KULR) (the "Company" or "KULR"), the advanced battery intelligence solution for autonomous platforms, digital infrastructure, e-mobility, and spaceflight applications, will hold a conference call on Tuesday, March 31st at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The financial results will be issued in a press release prior to the call. KULR management will host the conference call, followed by a question-and-answer period. Interested parties can submit relevant questions prior to the call to Stuart Smith via ema

    3/26/26 4:56:48 PM ET
    $KULR
    Electrical Products
    Technology

    Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

    GARDEN CITY, N.Y., March 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that Steve Lisi has resigned as Chief Executive Officer and stepped down from the Board of Directors, effective March 27, 2026, to pursue other opportunities. The Board of Directors has appointed Robert Goodman, the Company's current Chief Commercial Officer and Director, as Chief Executive Officer, effective today. For the past nine years, Mr. Lisi has led Beyond Air, guiding the development and launch of th

    3/26/26 4:05:00 PM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    $ACON
    $AGRI
    $ANY
    $AON
    SEC Filings

    View All

    SEC Form 10-K filed by Sphere 3D Corp.

    10-K - Sphere 3D Corp. (0001591956) (Filer)

    3/27/26 4:34:09 PM ET
    $ANY
    Finance: Consumer Services
    Finance

    SEC Form 144 filed by Liquidia Corporation

    144 - Liquidia Corp (0001819576) (Subject)

    3/27/26 4:27:07 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by DXC Technology Company

    SCHEDULE 13G - DXC Technology Co (0001688568) (Subject)

    3/27/26 4:20:02 PM ET
    $DXC
    EDP Services
    Technology

    $ACON
    $AGRI
    $ANY
    $AON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    FedEx upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded FedEx from Reduce to Hold and set a new price target of $360.00

    3/20/26 10:14:10 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Bernstein initiated coverage on Immunovant Sciences with a new price target

    Bernstein initiated coverage of Immunovant Sciences with a rating of Mkt Perform and set a new price target of $28.00

    3/20/26 8:36:14 AM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Needham initiated coverage on Fluence

    Needham initiated coverage of Fluence with a rating of Hold

    3/20/26 8:36:04 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $ACON
    $AGRI
    $ANY
    $AON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACON
    $AGRI
    $ANY
    $AON
    Financials

    Live finance-specific insights

    View All

    KULR Technology Group Sets Fourth Quarter and Full Year 2025 Earnings Call for Tuesday, March 31, 2026 at 4:30 p.m. ET

    HOUSTON, March 26, 2026 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE:KULR) (the "Company" or "KULR"), the advanced battery intelligence solution for autonomous platforms, digital infrastructure, e-mobility, and spaceflight applications, will hold a conference call on Tuesday, March 31st at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The financial results will be issued in a press release prior to the call. KULR management will host the conference call, followed by a question-and-answer period. Interested parties can submit relevant questions prior to the call to Stuart Smith via ema

    3/26/26 4:56:48 PM ET
    $KULR
    Electrical Products
    Technology

    FedEx Reports Strong Third Quarter Results

    Raises Full-year Fiscal 2026 Earnings Outlook On Track to Spin Off FedEx Freight on June 1, 2026 FedEx Corp. (NYSE:FDX) today reported the following consolidated results for the third quarter ended February 28 (adjusted measures exclude the items listed below):   Fiscal 2026   Fiscal 2025   As Reported (GAAP)   Adjusted (non-GAAP)   As Reported (GAAP)   Adjusted (non-GAAP) Revenue $24.0 billion   $24.0 billion   $22.2 billion   $22.2 billion Operating income $1.35 billion   $1.62 billion   $1.29 billion  

    3/19/26 4:06:00 PM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AGRI
    $ANY
    $AON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Clear Channel Outdoor Holdings Inc.

    SC 13D/A - Clear Channel Outdoor Holdings, Inc. (0001334978) (Subject)

    12/4/24 5:00:38 PM ET
    $CCO
    Advertising
    Consumer Discretionary

    SEC Form SC 13G filed by MacroGenics Inc.

    SC 13G - MACROGENICS INC (0001125345) (Subject)

    11/20/24 10:44:27 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by CARGO Therapeutics Inc.

    SC 13G/A - CARGO Therapeutics, Inc. (0001966494) (Subject)

    11/14/24 5:45:26 PM ET
    $CRGX

    $ACON
    $AGRI
    $ANY
    $AON
    Leadership Updates

    Live Leadership Updates

    View All

    Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

    GARDEN CITY, N.Y., March 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that Steve Lisi has resigned as Chief Executive Officer and stepped down from the Board of Directors, effective March 27, 2026, to pursue other opportunities. The Board of Directors has appointed Robert Goodman, the Company's current Chief Commercial Officer and Director, as Chief Executive Officer, effective today. For the past nine years, Mr. Lisi has led Beyond Air, guiding the development and launch of th

    3/26/26 4:05:00 PM ET
    $XAIR
    Medical/Dental Instruments
    Health Care

    argenx announces Annual General Meeting of Shareholders on May 6, 2026

    March 20, 2026 Amsterdam, the Netherlands – argenx SE ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Annual General Meeting of shareholders will be held at 13:00 CET on Wednesday, May 6, 2026 at the Hilton Amsterdam Schiphol at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.The shareholders and all other persons with meeting rights are invited to attend the Annual General Meeting of shareholders. The formal notice of convocation (including information on attending the meeting in person or by proxy, requirements for notification and registration for the meeting a

    3/20/26 4:01:00 PM ET
    $ARGX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Aon Appoints Anne Corona as CEO of North America, Elevates Lori Goltermann as Vice Chair and Appoints Farheen Dam as CEO of Enterprise Clients and Chief Client Officer

    DUBLIN, March 10, 2026 /CNW/ -- Aon plc (NYSE:AON), a leading global professional services firm, announced today that it is transitioning the North America CEO role from Lori Goltermann to Anne Corona, effective immediately, and has elevated Goltermann to serve as Vice Chair of Aon, effective March 31, 2026. With this transition, Farheen Dam has been appointed to serve as CEO of Enterprise Clients and Chief Client Officer, effective immediately. Corona, Goltermann and Dam report to Aon President and CEO Greg Case and serve on the Aon Executive Committee.As CEO of North America, Corona will build on the firm's momentum in the region delivering actionable insights, differentiated Risk Capital

    3/10/26 8:30:00 AM ET
    $AON
    Specialty Insurers
    Finance